Montani D, Lau EM, Dorfmüller P, Girerd B, Jaïs X, Savale L, Perros F, Nossent E, Garcia G, Parent F, et al. Pulmonary veno-occlusive disease. Eur Respir J. 2016;47:1518–34.

Article  PubMed  Google Scholar 

Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019, 53.

Ranchoux B, Günther S, Quarck R, Chaumais MC, Dorfmüller P, Antigny F, Dumas SJ, Raymond N, Lau E, Savale L, et al. Chemotherapy-induced pulmonary hypertension: role of alkylating agents. Am J Pathol. 2015;185:356–71.

Article  CAS  PubMed  Google Scholar 

Mandel J, Mark EJ, Hales CA. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med. 2000;162:1964–73.

Article  CAS  PubMed  Google Scholar 

Perros F, Günther S, Ranchoux B, Godinas L, Antigny F, Chaumais MC, Dorfmüller P, Hautefort A, Raymond N, Savale L, et al. Mitomycin-Induced Pulmonary Veno-Occlusive Disease: evidence from Human Disease and Animal models. Circulation. 2015;132:834–47.

Article  CAS  PubMed  Google Scholar 

Ohta S. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. Pharmacol Ther. 2014;144:1–11.

Article  CAS  PubMed  Google Scholar 

Huang CS, Kawamura T, Toyoda Y, Nakao A. Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res. 2010;44:971–82.

Article  CAS  PubMed  Google Scholar 

Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13:688–94.

Article  CAS  PubMed  Google Scholar 

Qian L, Wu Z, Cen J, Pasca S, Tomuleasa C. Medical Application of Hydrogen in Hematological Diseases. Oxid Med Cell Longev 2019, 2019:3917393.

Liu X, Ma C, Wang X, Wang W, Li Z, Wang X, Wang P, Sun W, Xue B. Hydrogen coadministration slows the development of COPD-like lung disease in a cigarette smoke-induced rat model. Int J Chron Obstruct Pulmon Dis. 2017;12:1309–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu W, Li D, Hu J, Mei H, Shu J, Long Z, Yuan L, Li D, Guan R, Li Y, et al. Hydrogen gas inhalation protects against cigarette smoke-induced COPD development in mice. J Thorac Dis. 2018;10:3232–43.

Article  PubMed  PubMed Central  Google Scholar 

He B, Zhang Y, Kang B, Xiao J, Xie B, Wang Z. Protection of oral hydrogen water as an antioxidant on pulmonary hypertension. Mol Biol Rep. 2013;40:5513–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang C, Lu W, Luo X, Liu S, Li Y, Zheng Q, Liu W, Wu X, Chen Y, Jiang Q, et al. Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats. Br J Pharmacol. 2021;178:217–35.

Article  CAS  PubMed  Google Scholar 

Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43:3618–731.

Article  CAS  PubMed  Google Scholar 

Kunadu A, Stalls JS, Labuschagne H, Thayyil A, Falls R, Maddipati V. Mitomycin induced pulmonary veno-occlusive disease. Respir Med Case Rep. 2021;34:101437.

PubMed  PubMed Central  Google Scholar 

Certain MC, Chaumais MC, Jaïs X, Savale L, Seferian A, Parent F, Georges M, Favrolt N, Bourdin A, Boissin C, et al. Characteristics and long-term outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C. Chest. 2021;159:1197–207.

Article  CAS  PubMed  Google Scholar 

Gagnadoux F, Capron F, Lebeau B. Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. Lung Cancer. 2002;36:213–5.

Article  CAS  PubMed  Google Scholar 

Perros F, Cohen-Kaminsky S, Gambaryan N, Girerd B, Raymond N, Klingelschmitt I, Huertas A, Mercier O, Fadel E, Simonneau G, et al. Cytotoxic cells and granulysin in pulmonary arterial hypertension and pulmonary veno-occlusive disease. Am J Respir Crit Care Med. 2013;187:189–96.

Article  CAS  PubMed  Google Scholar 

Neubert L, Borchert P, Stark H, Hoefer A, Vogel-Claussen J, Warnecke G, Eubel H, Kuenzler P, Kreipe HH, Hoeper MM, et al. Molecular Profiling of Vascular Remodeling in Chronic Pulmonary Disease. Am J Pathol. 2020;190:1382–96.

Article  CAS  PubMed  Google Scholar 

Kang KM, Kang YN, Choi IB, Gu Y, Kawamura T, Toyoda Y, Nakao A. Effects of drinking hydrogen-rich water on the quality of life of patients treated with radiotherapy for liver tumors. Med Gas Res. 2011;1:11.

Article  PubMed  PubMed Central  Google Scholar 

Saitoh Y, Harata Y, Mizuhashi F, Nakajima M, Miwa N. Biological safety of neutral-pH hydrogen-enriched electrolyzed water upon mutagenicity, genotoxicity and subchronic oral toxicity. Toxicol Ind Health. 2010;26:203–16.

Article  CAS  PubMed  Google Scholar 

Ohta S. Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic applications. Curr Pharm Des. 2011;17:2241–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Jing L, Zhao XM, Han JJ, Xia ZL, Qin SC, Wu YP, Sun XJ. Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model. Respir Res. 2011;12:26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heukels P, Corneth OBJ, van Uden D, van Hulst JAC, van den Toorn LM, van den Bosch AE, Wijsenbeek MS, Boomars KA, Kool M, Hendriks RW. Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension. Thorax. 2021;76:1209–18.

Article  PubMed  Google Scholar 

Ryter SW. Targeting AMPK and the Nrf2/HO-1 axis: a promising therapeutic strategy in acute lung injury. Eur Respir J 2021.

Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86:583–650.

Article  CAS  PubMed  Google Scholar 

Waza AA, Hamid Z, Ali S, Bhat SA, Bhat MA. A review on heme oxygenase-1 induction: is it a necessary evil. Inflamm Res. 2018;67:579–88.

Article  CAS  PubMed  Google Scholar 

Raval CM, Lee PJ. Heme oxygenase-1 in lung disease. Curr Drug Targets. 2010;11:1532–40.

Article  CAS  PubMed  Google Scholar 

An L, Liu CT, Yu MJ, Chen ZH, Guo XG, Peng W, Wang JF, Fang XQ, Gao YH, Yu SY. Heme oxygenase-1 system, inflammation and ventilator-induced lung injury. Eur J Pharmacol. 2012;677:1–4.

Article  CAS  PubMed  Google Scholar 

Kawamura T, Huang CS, Peng X, Masutani K, Shigemura N, Billiar TR, Okumura M, Toyoda Y, Nakao A. The effect of donor treatment with hydrogen on lung allograft function in rats. Surgery. 2011;150:240–9.

Article  PubMed  Google Scholar 

Buchholz BM, Masutani K, Kawamura T, Peng X, Toyoda Y, Billiar TR, Bauer AJ, Nakao A. Hydrogen-enriched preservation protects the isogeneic intestinal graft and amends recipient gastric function during transplantation. Transplantation. 2011;92:985–92.

Article  CAS  PubMed  Google Scholar 

Fredenburgh LE, Perrella MA, Mitsialis SA. The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol. 2007;36:158–65.

Article  CAS  PubMed